BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xin Q, Xu F, Taylor DH, Zhao JF, Wu J. The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders. Acta Pharmacol Sin 2020;41:1507-18. [PMID: 33024239 DOI: 10.1038/s41401-020-00530-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Ishiguro H, Kibret BG, Horiuchi Y, Onaivi ES. Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders. Front Psychiatry 2022;13:828895. [DOI: 10.3389/fpsyt.2022.828895] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhang L, Wang X, Yu W, Ying J, Fang P, Zheng Q, Feng X, Hu J, Xiao F, Chen S, Wei G, Lin Y, Liu X, Yang D, Fang Y, Xu G, Hua F. CB2R Activation Regulates TFEB-Mediated Autophagy and Affects Lipid Metabolism and Inflammation of Astrocytes in POCD. Front Immunol 2022;13:836494. [PMID: 35392078 DOI: 10.3389/fimmu.2022.836494] [Reference Citation Analysis]
3 Kibret BG, Ishiguro H, Horiuchi Y, Onaivi ES. New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders. Int J Mol Sci 2022;23:975. [PMID: 35055161 DOI: 10.3390/ijms23020975] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
4 Ji X, Zeng Y, Wu J. The CB2 Receptor as a Novel Therapeutic Target for Epilepsy Treatment. Int J Mol Sci 2021;22:8961. [PMID: 34445666 DOI: 10.3390/ijms22168961] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]